Brief: Petros Pharmaceuticals Inc Announces $5.7 Mln Registered Direct Offering
14/10/2021 14:11
Oct 14 (Reuters) - Petros Pharmaceuticals Inc PTPI.O :
* PETROS PHARMACEUTICALS ANNOUNCES $5.7 MILLION REGISTERED
DIRECT
OFFERING
* PETROS PHARMACEUTICALS - ENTERED INTO AGREEMENTS WITH
LARGEST
INVESTOR, OTHER INVESTORS, FOR PURCHASE, SALE OF 3.3 MILLION
SHARES AT PRICE OF $1.715/SHARE
* PETROS PHARMACEUTICALS INC - FINANCING WAS LED BY
COMPANY'S
LARGEST SHAREHOLDER
Source text for Eikon: ID:nPn8T6kSfa
Further company coverage: PTPI.O
Recent news on Petros Pharmaceuticals
See all newsBrief: Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors
Brief: Petros Pharmaceuticals’ STENDRA Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Brief: Petros Pharmaceuticals Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Petros Pharmaceuticals Expands Online Distribution For Prescription STENDRA(R) Through New Agreement With Lemonaid Health
Brief: Petros Pharma Announces Partnership with Idea Evolver for Rx-to-OTC Switches & Digital Launch Solutions